These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18243699)

  • 21. Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
    El-Tayeb A; Iqbal J; Behrenswerth A; Romio M; Schneider M; Zimmermann H; Schrader J; Müller CE
    J Med Chem; 2009 Dec; 52(23):7669-77. PubMed ID: 19580286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions of adenosine A 2A receptors on synaptic connections of spiny projection neurons in the neostriatal inhibitory network.
    Shindou T; Arbuthnott GW; Wickens JR
    J Neurophysiol; 2008 Apr; 99(4):1884-9. PubMed ID: 18272872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease.
    Votto JJ; Bowen JB; Barton RW; Thrall RS
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):329-34. PubMed ID: 18800883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine A(2A) agonists as therapy for glomerulonephritis.
    Ferenbach DA; Hughes J
    Kidney Int; 2011 Aug; 80(4):329-31. PubMed ID: 21799503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.
    Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD
    Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists.
    Shao Y; Cole AG; Brescia MR; Qin LY; Duo J; Stauffer TM; Rokosz LL; McGuinness BF; Henderson I
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1399-402. PubMed ID: 19181527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of somatostatin release by adenosine in the mouse stomach.
    Yang GK; Chen JF; Kieffer TJ; Kwok YN
    J Pharmacol Exp Ther; 2009 May; 329(2):729-37. PubMed ID: 19208896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
    Rochat T; Janssens JP
    Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in intracellular cyclic AMP formation mask opposing modulation of kainate-enhanced glutamate release in the striatum.
    Dohovics R; Janáky R; Varga V; Saransaari P; Oja SS
    Proc West Pharmacol Soc; 2004; 47():35-8. PubMed ID: 15633607
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
    Black PN; McDonald CF
    Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA; Fabbri LM; Davis KJ; Soriano JB
    Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
    van Veldhoven JP; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Struensee-Link R; Beukers MW; Brussee J; IJzerman AP
    Bioorg Med Chem; 2008 Mar; 16(6):2741-52. PubMed ID: 18258439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S; Amin AV; Loke YK
    Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.